Article
TCT: Vascepa (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior
Rating:
0.0
Views:
62
Likes:
1
Library:
1
VASCEPA®, compared with placebo, significantly reduced primary composite first and total MACE (major adverse cardiovascular events) in post hoc exploratory analyses of patients with a history of PCI by 34% and
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value